Skip to main content
Premium Trial:

Request an Annual Quote

Cincinnati Children's, Claritas Partner on Pediatric Genomics

NEW YORK (GenomeWeb News) – Cincinnati Children's Medical Center and Claritas Genomics today announced a partnership to build a network for pediatric hospitals to share data, expertise, best practices, and infrastructure in genetics and genomics.

Cincinnati Children's also is making a financial investment in Claritas, which was launched earlier this year as a partnership between Life Technologies and Boston Children's Hospital. The partners did not disclose the amount of the investment. They said that Claritas' Series A round closed with two additional strategic investors, and the investments "bring the new venture close to a scalable, practical paradigm for advancing genetic and genomic research discoveries and bringing them to appropriate clinical use."

Claritas is focused on developing diagnostic tests for inherited pediatric diseases and currently offers more than 100 specialty tests.

"Given the expertise at pediatric hospitals in genomics specifically, the knowledge required to determine the full clinical impact of a patient's genome, and the ethical approaches to responsibly act on the information, patients will benefit from our pediatric hospitals working together in new ways," Cincinnati Children's Research Foundation Director Arnold Strauss said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.